Drosophila melanogaster plasmatocytes, the phagocytic cells among hemocytes, are essential for immune responses, but also play key roles from early development to death through their interactions with other cell types. They regulate homeostasis and signaling during development, stem cell proliferation, metabolism, cancer, wound responses, and aging, displaying intriguing molecular and functional conservation with vertebrate macrophages. Given the relative ease of genetics in Drosophila compared to vertebrates, tools permitting visualization and genetic manipulation of plasmatocytes and surrounding tissues independently at all stages would greatly aid a fuller understanding of these processes, but are lacking. Here, we describe a comprehensive set of transgenic lines that allow this. These include extremely brightly fluorescing mCherry-based lines that allow GAL4-independent visualization of plasmatocyte nuclei, the cytoplasm, or the actin cytoskeleton from embryonic stage 8 through adulthood in both live and fixed samples even as heterozygotes, greatly facilitating screening. These lines allow live visualization and tracking of embryonic plasmatocytes, as well as larval plasmatocytes residing at the body wall or flowing with the surrounding hemolymph. With confocal imaging, interactions of plasmatocytes and inner tissues can be seen in live or fixed embryos, larvae, and adults. They permit efficient GAL4-independent Fluorescence-Activated Cell Sorting (FACS) analysis/sorting of plasmatocytes throughout life. To facilitate genetic studies of reciprocal signaling, we have also made a plasmatocyte-expressing QF2 line that, in combination with extant GAL4 drivers, allows independent genetic manipulation of both plasmatocytes and surrounding tissues, and GAL80 lines that block GAL4 drivers from affecting plasmatocytes, all of which function from the early embryo to the adult.

Aberrant display of the truncated core1 O-glycan T-antigen is a common feature of human cancer cells that correlates with metastasis. Here we show that T-antigen in Drosophila melanogaster macrophages is involved in their developmentally programmed tissue invasion. Higher macrophage T-antigen levels require an atypical major facilitator superfamily (MFS) member that we named Minerva which enables macrophage dissemination and invasion. We characterize for the first time the T and Tn glycoform O-glycoproteome of the Drosophila melanogaster embryo, and determine that Minerva increases the presence of T-antigen on proteins in pathways previously linked to cancer, most strongly on the sulfhydryl oxidase Qsox1 which we show is required for macrophage tissue entry. Minerva’s vertebrate ortholog, MFSD1, rescues the minerva mutant’s migration and T-antigen glycosylation defects. We thus identify a key conserved regulator that orchestrates O-glycosylation on a protein subset to activate a program governing migration steps important for both development and cancer metastasis.

8Aberrant display of the truncated core1 O-glycan T-antigen is a common feature of 9 human cancer cells that correlates with metastasis. Here we show that T-antigen in 10 Drosophila melanogaster macrophages is involved in their developmentally programmed 11 tissue invasion. Higher macrophage T-antigen levels require an atypical major facilitator 12 superfamily (MFS) member that we named Minerva which enables macrophage 13 dissemination and invasion. We characterize for the first time the T and Tn glycoform O-14 glycoproteome of the Drosophila melanogaster embryo, and determine that Minerva 15 increases the presence of T-antigen on protein pathways previously linked to cancer, 16 most strongly on the protein sulfhydryl oxidase Qsox1 which we show is required for 17 macrophage invasion. Minerva's vertebrate ortholog, MFSD1, rescues the minerva 18 mutant's migration and T-antigen glycosylation defects. We thus identify a key 19 conserved regulator that orchestrates O-glycosylation on a protein subset to activate a 20 program governing migration steps important for both development and cancer 21 metastasis. 22 23 §: These authors contributed equally 24 *-Corresponding author and lead contact,

No abstract